Correlation of FSTL1 and its paralogs with body composition in adult survivors of childhood cancer

Varování

Publikace nespadá pod Ústav výpočetní techniky, ale pod Lékařskou fakultu. Oficiální stránka publikace je na webu muni.cz.
Autoři

ŠTRUBLOVÁ Lucie ZLÁMAL Filip PISKOVSKÝ Tomáš KUČERA Jan FIALOVÁ KUČEROVÁ Jana KEPÁK Tomáš ŠTĚRBA Jaroslav DOBROVOLNÁ Julie

Rok publikování 2025
Druh Článek v odborném periodiku
Časopis / Zdroj Scientific Reports
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www https://www.nature.com/articles/s41598-025-03013-8
Doi http://dx.doi.org/10.1038/s41598-025-03013-8
Klíčová slova FSTL1; FSTL4; FSTL5; Adiposity; Skeletal muscle mass; Late effects; Childhood cancer survivors
Popis This retrospective, cross-sectional study investigated the relationship between body composition and circulating plasma levels of follistatin-like proteins (FSTLs; FSTL1, FSTL4, and FSTL5) in adult survivors of childhood cancer. This is the first study to investigate the association between plasma levels of FSTL4, FSTL5 and skeletal muscle mass. The cohort consisted of 61 CCS (26 females and 35 males) aged 18-36 years (mean age 24.6 +/- 4.4 years) who were followed up at the Long-Term Follow-Up Clinic of St. Anne's Hospital in Brno, Czech Republic. The mean age at diagnosis was 10.9 +/- 4.9 years, and the mean time after treatment was 12.0 +/- 5.1 years. Body composition was assessed using anthropometric indicators and bioelectrical impedance analysis (BIA; InBody 370). Plasma FSTL levels were quantified using commercially available ELISA kits. Correlations were examined by linear regression analysis. A significant negative correlation was found between the FSTL1 plasma level and body fat mass index (BFMI), and a significant positive correlation was observed between FSTL1 and skeletal muscle mass index (SMI). Our results suggest that FSTL1 may be a potential indicator of adiposity and skeletal muscle loss in CCS.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info